References
- Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM: Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111: 777–784.
- Parker MJ, Budd JL, Draper ES, Young ID: Trisomy 13 and trisomy 18 in a defined population: epidemiological, genetic and prenatal observations. Prenat Diagn 2003; 23: 856–860.
- Snijders RJM, Sebire NJ, Nicolaides KH: Maternal age and gestational age-specific risk for chromosome defects. Fetal Diagn Ther 1995; 10: 356–367.
- Taslimi MM, Acosta R, Chueh J, Hudgins L, Hunter K, Chitkara U: Detection of sonographic markers of fetal aneuploidy depends on maternal and fetal characteristics. J Ultrasound Med 2005; 24: 811–815.
- Lehman CD, Nyberg DA, Winter TC, Kapur RP, Resta RG, Luthy DA: Trisomy 13 syndrome: prenatal US findings in a review of 33 cases. Radiology 1995; 194: 217–222.
- NHS Fetal Anomalous Screening Programme: Chorionic villus sampling (CVS) and amniocentesis leaflet update and published in html. FASP 2020; https://phescreening.blog.gov.uk/2020/02/28/cvs-aminocentesis-leaflet-html/.
- Royal College of Obstetricians and Gynaecologists (RCOG): Chorionic villus sampling and amniocentesis. Information for you. RCOG Press: London, 2011. https://www.rcog.org.uk/en/patients/patient-leaflets/amniocentesis-and-chorionic-villus-sampling/.
- American College of Obstetricians and Gynecologists: ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.. Obstet Gynecol 2007; 110: 1459–1467.
- Wilson RD, Langlois S, Johnson JA: Mid-trimester amniocentesis fetal loss rate. J Obstet Gynaecol Can 2007; 29: 586–595.
- Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R: Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 2019; 54: 442–451.
- Cell-free fetal DNA testing in prenatal genetic screening. Polish Gynaecological Society and Polish Human Genetics Society guidelines. Ginekol Pol 2015; 86: 966–969.
- Salmanian B, Shamshirsaz AA, Cass DL, Javadian P, Ruano R, Ayres NA et al.: Fetal cardiac tamponade in a case of right-side congenital diaphragmatic hernia. Obstet Gynecol 2014; 123: 447–450.
- Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH: Increased nuchal translucency in trisomy 13 fetuses at 10±14 weeks of gestation. Am J Med Genet 1999; 86: 205–207.
- Spencer K, Ong Ch, Skentou H, Liao AW, Nicolaides KH: Screening for trisomy 13 by fetal nuchal translucency and maternal serum free b-hCG and PAPP-A at 10–14 weeks of gestation. Prenat Diagn 2000; 20: 411–416.
- Hyett JA, Noble PL, Snijders RJ, Montenegro N, Nicolaides KH: Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 239–244.
- Liao AW, Snijders R, Geerets L, Spencer K, Nicolaides KH: Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 2000; 16: 610–613.
- Turan O, Hirfanoglu IM, Beken S, Biri A, Efeturk T, Atalay Y: Prenatally detected congenital cystic adenomatoid malformation and postnatally diagnosed trisomy 13: case report and review of the literature. Turkish J Pediatr 2011; 53: 337–341.
- Ki KD, Kim SR, Lee WI: Increased fetal nuchal translucency as a sole clue in the prenatal diagnosis of a fetus with trisomy 13. Fetal Diagn Ther 2009; 26: 54–56.